Aranas, Fredilyn V.
HRN: 22-80-44 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/29/2023
CEFUROXIME 500MG (TAB)
03/29/2023
04/05/2023
PO
500mg
Q12H
S/P Excision Biopsy Of Nasal Polyp
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes